J-Pharma
Yokohama
About J-Pharma
J-Pharma’s mission is to help mankind by creating and developing novel pharmaceuticals based upon a human-genomic approach; an approach where people with specific diseases are treated with novel and selective agents. J-Pharma’s intellectual property (IP) embraces the notion that cell membrane transporters are tightly associated to many diseases. In addition to drug molecules that target specific transporters, J-Pharma has discovered several important drug transporters within the human body that may be used to evaluate and optimize pharmacokinetics of new drug candidates. We believe that J-Pharma’s pipelines will lead to new agents and processes (i.e. diagnostic methods) and will increase the quality of life for an ageing population in industrialized countries. J-Pharma’s overall goal is to contribute globally to the maintenance of human health and improve human welfare through the creation of new drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Funding stage: Late Stage Venture
- Last round: Series D (Jan 2021)
- Website: j-pharma.com
- Phone: +81 045-506-1155
Industries & Categories
Biotechnology, Medical, Nursing and Residential Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/j-pharma-65757 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.